Evotec SE

Research Evotec SE (EVO) on Bullrun: market cap USD 994.49M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerEVO
• ExchangeNASDAQ
• CountryGermany
• SectorHealthcare
• IndustryDrug Manufacturers-Specialty & Generic
• CurrencyUSD
• Market capUSD 994.49M
• Financial periodQ1 2026
• RevenueUSD 156.64M
• Net income-USD 121.94M
• Free cash flow-USD 14.70M
• Gross margin-1.0%

Valuation Snapshot

latest market cap is USD 994.49M.

About Evotec SE

Evotec SE operates as a drug discovery and development company in the United States, Germany, France, the United Kingdom, Switzerland, and internationally. It operates in two segments, Shared R&D and Just – Evotec Biologics. The company is developing pharmaceutical products in various therapeutic areas, such as oncology, autoimmune, cancer, diabetes, heart failure, immunology, pain and inflammation, infectious, kidney, liver, respiratory, fibrotic and metabolic diseases, and rare diseases.

Frequently asked questions

What is Evotec SE's market cap?

Evotec SE's market capitalization is USD 994.49M.

What does Evotec SE do?

Evotec SE operates as a drug discovery and development company in the United States, Germany, France, the United Kingdom, Switzerland, and internationally. It operates in two segments, Shared R&D and Just – Evotec Biologics.